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day I, correlated well to vaspin concentrations (r2 = 0.201, 
p = 0.011). ATP levels were significantly lower in patients 
vs. controls (day I: p = 0.00012; day IV: p = 0.0001). 
Conclusions: Changes in the analyzed visfatin and vaspin 
concentrations can be used as potential MI markers. 
Visfatin serum concentration may be considered a 
potential marker to differentiate MI over time.
Keywords: myocardial infarction, visfatin, vaspin, 
adenine nucleotides, uric acid
1  Introduction
Adipocytokines are a large group of bioactive proteins 
and they manifest hormone-like attributes with properites 
similar to some chemokines, cytokines and growth factors. 
Specific changes in the circulatory levels of adipokines 
appear to have a proatherogenic, proinflammatory and 
anti-insulin effects on human cells [1]. 
Visfatin is an adipokine mainly expressed in visceral 
fat tissue, and is also produced in the myocardium, bone 
marrow, skeletal muscle, and liver [2]. Visfatin occurs in a 
form of a dimer, capable of binding and hydrolyzing ATP. 
Visfatin undergoes self-phosphorylation which enhances 
its catalytic function in nicotinate and nicotinamide 
metabolism [2]. Increased visfatin serum levels were found 
in some diseases associated with obesity, atherogenesis 
and insulin-resistance [3]. Visfatin has been considered 
as a pro-inflammatory factor and is also associated with 
vascular smooth muscle cell maturation and plaque 
destabilization [2,4]. The plasma visfatin level was found 
to be elevated in patients with acute ST-segment elevation 
myocardial infarction (STEMI) [5].
Vaspin, identified in 2005, is a serine protease inhibitor 
secreted only by visceral fat tissue [6]. In animal models, 
it has been shown that vaspin enhances insulin sensitivity 
in peripheral tissues thus improving glucose tolerance, 
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Abstract: Introduction: The association of vaspin 
and visfatin, with a myocardial infarction is still 
not fully understood. Reduced levels of adenine 
nucleotides are hallmarks of chronic heart failure. 
There is little data concerning the relationship 
between these markers and their changes over time. 
Material/Methods: The concentration of adenine 
nucleotides, vaspin and visfatinwere assessed in 41 
consecutive patients with acute myocardial infarction one 
before (day I) and four days  after (day IV) percutaneous 
coronary intervention (PCI) and a control group. 
Results: Visfatin concentrations were higher before and 
after PCI vs. control (visfatin I: median 25.55, 20.12 - 30.69 
ng/ml; visfatin IV: median 20.79, 16.89 - 25.61 ng/ml vs. 
control: median 14.94, 10.66 - 25.25 ng/ml; p < 0.0001). 
Vaspin concentrations were lower before and after PCI vs. 
control (vaspin I: median 0.18, 0.11 - 0.44 ng/ml; vaspin IV: 
median 0.24, 0.15 - 0.58 ng/ml vs. control: median 1.303, 
1.13 - 2.26 ng/ml, p < 0.00001). Concentrations of visfatin, 
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Physiology in Zabrze of Silesian University of Medicine. 
The study population included 41 men (aged mean 55.1 
± 9.7) with myocardial infarction. Myocardial infarction 
was defined following current ESC guidelines [21]. All 
patients were qualified for invasive coronary diagnostic 
treatment (percutaneous coronary interventions) for the 
first time in their lives. The inclusion criteria were as 
follows: typical angina pain for < 12 h until admission 
to the hospital, ST-segment elevation during resting 
12-lead ECG, increased myocardial necrotic markers 
in the serum: troponin-I and CK-MB or non-elevated 
ST-segment but increased troponin-I and CK-MB levels. 
Exclusion criteria: pulmonary oedema, cardiogenic 
shock or contraindications for catheterization, primary 
cardiomyopathies, myocardial infarction in the last 
6  months, unstable angina, significant valvular heart 
defects, severe chronic heart failure (class NYHA III-IV), 
inflammatory conditions, acute or chronic infectious 
disease, malignant disease, and including any kind of 
a surgical procedure or serious injury 6 months prior 
to admission to the hospital. Every patient was treated 
according to the guidelines. Additional pharmacotherapy 
was induced when individual clinical indications 
occurred. Blood samples were collected upon admission 
to the hospital before PCI (I day) and four days after PCI 
following an overnight fast(IV day).
The control group consisted of 30 healthy men (aged 
46.5 ± 7.4). These individuals did not suffer from chronic 
disease, cardiovascular disease and did not present overt 
cardiac origin symptoms. Each patient from the control 
group was evaluated for inclusion in the study. Informed 
consent was obtained in each case.
2.2  Clinical evaluation
Six patients suffered from type 2 diabetes mellitus, 
having a mean fasting blood glucose level higher than 
6.9 ± 1.9 mmol/l and a glycated hemoglobin HbA1C > 
6%. The majority of the patients (92.6%) suffered from 
hypertension. Body mass index (BMI) was calculated from 
measured, not declared data, and expressed in kg/m2. 
Each patient’s left ventricle contraction (left ventricular 
ejection fraction) was assessed by echocardiography. A 12 
lead ECG was recorded. 
2.3  Ethical Considerations
The study was approved by the Ethics Committee of 
the Medical University of Silesia in Katowice (approval 
however elevated vaspin serum concentrations were 
associated with insulin resistance and a lower fitness 
level [7]. A low vaspin level is suggested to be involved 
in the pathophysiology of coronary atherosclerosis, 
microvascular complications in coronary artery disease and 
carotid stenosis [8-10]. Serum vaspin concentrations were 
proven to be associated with carotid stenosis in patients 
with acute ischemic stroke and patients who underwent 
carotid endarterectomy [11]. Diabetes and body weight loss 
were shown to decrease vaspin expression, which can be 
also normalized by insulin or pioglitazone treatment [12,13]. 
Certain adipokines are considered to be a new link between 
metabolic diseases, atherosclerosis and cardiovascular 
disease, with visfatin and vaspin suggested as novel factors 
involved in atherosclerosis progression [9]. 
ATP nucleotide (adenosine triphosphate) plays an 
important role in cell biology, as a multifunctional coenzyme 
and molecular unit in intracellular energy transfer [14,15]. 
Reduced levels of total adenine nucleotides ATP, ADP 
(adenosine diphosphate) and AMP are hallmarks of chronic 
heart failure [16]. Currently, there are no published reports 
investigating the relationship between these adenine 
nucleotides levels and myocardial infarction patients.
Uric acid (UA) has been widely investigated as the 
prognostic factor for a number of cardiovascular diseases. 
Elevated levels of UA are associated with the mortality in 
the general population, and in patients with congestive 
heart failure, hypertension, diabetes, coronary artery 
disease and acute myocardial infarction. Uric acid is 
considered a variable parameter, which strongly depends 
on the metabolic condition of the patient. It is reported, 
that alterred and increased UA levels are associated with 
obesity, raised blood pressure, hyperlipidemia, glucose 
intolerance, and CVD clustering. In patients with stable 
coronary artery disease, uric acid predicts the risk of death 
independently from cardiovascular risk factor, status of 
renal function or inflammation risk. Nevertheless, the 
mechanisms between UA level and poor prognosis are not 
fully understood [17-20]. 
The aim of the study was to investigate visfatin and 
vaspin concentrations, the total adenine nucleotides 
and uric acid states in relation to the dynamics of acute 
coronary syndrome. 
2  Material and Methods 
2.1   Subjects and study design
This cross-sectional study was conducted at the Silesian 
Center for Heart Diseases and at the Department of 
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3  Results 
Biochemical, demographical and cardiological 
characteristics of all the patients included in the study 
are presented in Table 1. Intergroup statistical analysis 
revealed that the visfatin levels in patients with MI 
were significantly higher before (day I) and four days 
after (day IV) PCI compared with healthy individuals 
(Visfatin-I median 25.55, 20.12 - 30.694 ng/ml; 
p = 0.00001; Visfatin-IV median 20.79, 16.89 - 25.61 ng/ml 
vs. control median 14.94, 10.66 - 25.25 ng/ml; p < 0.00001, 
Fig. 1). Vaspin concentrations in patients with MI were 
significantly lower I and IV days after PCI compared to 
healthy individuals (Vaspin-I median 0.18, 0.11 - 0.44 ng/ml; 
Vaspin-IV median 0.24, 0.15 - 0.58 ng/ml vs. control 
median 1.30, 1.13 - 2.26 ng/ml, p < 0.00001) (Fig. 2). 
Visfatin levels measured on day I were significantly 
correlated to vaspin concentraions (r2 = 0.201, p = 0.01). 
Visfatin concentration 4 days after PCI was related to 
the following parameters: ADP (r2 = 0.51, p = 0.000006); 
NADP (r2 = 0.57, p = 0.000001); ATP/ADP (r2 = 0.56, 
p = 0.000001); UA (r2 = 0.15, p = 0.02) (Table 2).
The whole blood concentration of ATP was 
significantly lower in examined patients when 
compared to the controls (ATP-I 495.2 ± 62.4 µmol/l, 
p = 0.00012; ATP-IV 513.7 ± 70.6 µmol/l, p = 0.0001 vs. 
control 604.2 ± 61.2 µmol/l; Fig.3.). The concentration of 
adenosine diphosphate (ADP) in every analyzed group 
did not differ from control, Fig.3. The concentration 
of AMP was significantly higher on day I and day IV 
after PCI compared to the control group (AMP-I 7.54 
± 2.7; AMP-IV 7.25 ± 2.1 vs. control 4.6 ± 1.6 µmol/l, 
p = 0.0001) (Fig. 4). The ratio of ATP/ADP in whole blood 
samples was significantly lower in ATP/ADP-I group when 
compared to the control (ATP/ADP-1 7.79 ± 1.12 vs. control 
8.75 ± 0.77 µmol/l; p = 0.005; Fig. 4). The level of NADP 
and NAD were significantly lower on day I and IV after 
PCI in comparison to the control group (NADP-I 15.63 
± 1.89; NADP-IV 15.74 ± 2.32 vs. control 18.92 ± 1.93 µmol/l, 
p = 0.00014; p = 0.0002; NAD-I 21.37 ± 5.27; NAD-IV 
21.17 ± 4.68 vs. control 27.74 ± 3.69 µmol/l; p = 0.00017; 
p = 0.0002; Fig.5). The level of uric acid in the blood of 
patients from the UA-I group was significantly lower 
compared with the control group (UA-I 88.07 ± 29.5 vs. 
control 115.54 ± 24.9 µmol/l, p = 0.005; Fig.6). We further 
analyzed correlative relationships between adenine 
nucleotides and adipokine concentrations and found 
significant correlations (p < 0.05) among selected adenine 
nucleotides and adipokines (Table 2). 
number KNW-1-001/P/1/0) and was in compliance with the 
ethical guidelines of the Declaration of Helsinki. Written 
informed consent was obtained from every patient before 
inclusion into the study series.
2.4  Blood analyses
Blood samples were collected from an antecubital vein 
and then placed into a BD Vacutainer containing 0.117 mL 
of 15% (k3) EDTA solution. For adipokines analysis, 
blood samples were immediately centrifuged at 2500 x g 
for 20  min to obtain serum and stored at - 80°C, 
thawing only once immediately before analysis. Vaspin 
concentrations were determined using a commercially 
available EIA kit (Human Vaspin ELISA kit, Catalogue no. 
V0712TP AdipoGen Inc., Seoul, Korea). The sensitivity of 
the set was 12 pg/ml. Visfatin concentration levels were 
determined enzymatically using a commercial ELISA 
Kit (C - terminal Visfatin (Human) EIA kit, Catalogue no. 
EK-003-80, Phoenix Pharmaceuticals, Inc., Belmont, CA, 
USA). The sensitivity of the set was 2.83 pg/ml.
Blood samples were used to assess the biochemical 
parameters (Table.1.). The measurement of biochemical 
parameters was performed with standard procedures 
at the Silesian Center of Heart Diseases laboratory on a 
ROCHE INTEGRA 800 (Roche Poland).
Concentrations of ATP and its inter-converts to ADP 
and AMP and uric acid were evaluated at the Department 
of Biochemistry of Gdansk Medical University, using high-
performance liquid chromatography (HPLC) according to 
the previously developed method by Smolensky [22].
2.5  Statistical analysis
The results of continuous variables are expressed as 
mean ± SD for all data except for the concentrations of 
vaspin and visfatin, where the median ± min/max was 
calculated. The normality of the distribution was assessed 
using Levene’s test. Comparisons between adenine 
nucleotidegroups were made using the post hoc HSD 
(Tukey’s T-test). Comparisons between concentrations of 
visfatin vaspin in patient and control groups were made 
using the Mann-Whitney U test. Correlations between 
parameters were calculated using the Spearman’s rank 
correlation test. Statistical significance was set at the 
p level < 0.05. All statistical analysis was performed using 
Statistica 10.0 (StatSoft, Poland).
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between visfatin and unstable lesions at the plaque rupture 
site in patients with acute myocardial infarction [2]. The 
increased visfatin plasma levels were also assessed in ACS 
[5,23]. The visfatin levels, in MI patients, peaked 24 h after 
MI and decreased during the first week in comparison to 
the control group [23]. Our results are consistent with this 
data and suggests that changes in this adipokine level may 
result from the repair processes present in myocardium. 
Increased concentrations of visfatin were shown to 
be significantly associated with a high risk of infarct-
related artery occlusion, where the plasma visfatin levels 
4  Discussion
The purpose of this study was to test the hypothesis that 
the levels of selected adipokines and nucleotides could 
show different dynamics over time and these levels can 
be altered before and after PCI. We demonstrated that the 
levels of visfatin were increased in patients with the MI, 
both before and 4 days after PCI. Visfatin serum levels 
on the day I and IV after PCI were around 1.6 and 1.3 
(respectively) times higher in patients with MI compared to 
healthy individuals. Dhal et al. described the relationship 
Table 1. Demographic, biochemical and cardiological parameters for patients included into the program.
Demographic parameters 
Age 55.19 ± 9.73
Smokers, N 8 (19.51%)
BMI [kg/m2] 28.08 ± 3.43
Hypertension, N 38 (92.6%)
Diabetes 2 mellitus, N 6 (14.63%)
Dislipidemia, N 25 (62.5%)
Cardiological parameters
LVEF [%] 48 ± 7
Angiography Number of patients
1-vessel 16
2-vessel 5
3-vessel 20
CAD score Number of patients
2 2
3 10
4 29
Biochemical parameters
Day I Day IV p
T-cholesterol [mmol/L] 5.26 ± 1.0 4.76 ± 1.17 0.00001
HDL [mmol/L] 1.22 ± 0.2 1.24 ± 0.05 0.975
LDL [mmol/L] 3.34 ± 0.8 2.95 ± 1.02 0.339
TG [mmol/L] 1.62 ± 1.6 1.64 ± 1.4 0.969
Glucose in blood[mmol/L] 6.7 ± 1.8 5.35 ± 0.6 0.001
*HbA1C % 6 - -
Leukocytosis [109/L] 11.04 ± 2.9 8.8 ± 0.9 0.0001
Erythrocytes[mln/mm3] 4.8± 0.4 4.6 ± 0.5 0.235
Hemoglobin [mmol/L] 9.3 ± 1.0 8.8 ± 0.9 0.08
Hematocrit [L/L] 0.43 ± 0.04 0.41 ± 0.03 0.219
CRP [mg/dL] 42.94 ± 34.59 - -
CK – MBI [ng/mL] 58.54 ± 11.8 92.1± 11.3 0.267
Troponin[ng/mL] 0.51 ± 0.8 1.9± 1.4 0.004
Creatinine [μmol/L] 80 ± 18 78.6 ± 15.0 0.797
AspAT [IU/l] 56.18 ± 61.3 90.5 ± 11.1 0.736
ALAT [IU/l] 38.8 ± 84 54 ± 8.0 0.036
Clinical data is presented as means ± SD, N- number of patients;* - measured only for diabetic group, p < 0.05.
BMI - body mass index, HDL-C – condensation of HDL cholesterol; LDL-C – condensation of LDL cholesterol, TG - triglycerides, HbA1C - the 
level of glycated hemoglobin, WBC - leukocytosis, LVEF - left ventricular ejection fraction; IU - International Units (International Unit), 
CK-MBI - creatine kinase, T-cholesterol - total cholesterol hsCRP - C-reactive protein test, SBP - systolic blood pressure, DBP - diastolic blood 
pressure, CAD – coronary artery disease.
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Figure 4. ATP/ADP ratio and AMP blood concentrations [µmol/L] 
in patients with MI at admission (day I) and four days after PCI fol-
lowing an overnight fast (day IV) in comparison to control.
Figure 5. NADP, NAD blood concentrations [µmol/L] in patients with 
MI at admission (day I) and four days after PCI following an over-
night fast (day IV) in comparison to control.
Figure 6. Uric acid (UA) blood concentrations [µmol/L] in patients 
with MI at admission (day I) and four days after PCI following an 
overnight fast (IV) in comparison to control.
Figure 2. Vaspin plasma levels [ng/mL] in patients with MI at admis-
sion (day I) and four days after PCI following an overnight fast (day 
IV) in comparison to control.
Figure 3. ATP, ADP blood concentrations [µmol/L] in patients with MI 
at admission (day I) and four days after PCI following an overnight 
fast (day IV) in comparison to control.
Figure 1. Visfatin plasma levels [ng/mL] in patients with MI at admis-
sion (day I) and four days after PCI following an overnight fast (day 
IV) in comparison to control.
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destabilization. The decrease in visfatin concentration 4 
days after PCI could be explained by the occurrence of 
repair processes, but further investigations are needed 
to explore whether the visfatin level would continuously 
decrease to the levels found within in a healthy subject.
We report that patients had reduced vaspin levels 
before (by 7 times) and after (by 5.5 times) PCI, when 
compared to healthy individuals. This result may indicate 
the effectiveness of the interventional treatment and the 
decrease of micro-inflammation. Further, we observed 
that day I vaspin values were negatively correlated with 
CRP levels. Literature has shown that, for patients with 
MI,  there is an association between lower circulating 
vaspin levels and the severity of CAD [9]. Vaspin has 
anti-atherosclerotic properties and its increasing 
concentration is a compensation mechanism for the 
developing atherosclerotic process [8]. Decreased vaspin 
mRNA expression in peripheral blood mononuclear cells 
was observed in patients with unstable angina pectoris 
in comparison with patients with stable CAD [24]. CAD is 
considered a systemic micro-inflammatory disease, and 
as it was shown that pro-inflammatory factors can reduce 
vaspin expression [25] and vaspin concentration, which 
is associated with a high level of C-reactive protein. The 
decreased vaspin level can be explained by the severity 
of acute coronary syndromes (ACS) in CAD. Further 
studies are required to confirm whether the significantly 
lower concentrations of circulating vaspin in patients 
with myocardial ischemia might be a predictor of this 
pathophysiological condition.
The region of myocardial infarction contains a 
difference of perfusion levels. In regions of relatively severe 
ischemia, glycolysis and oxidative phosphorylation may 
be inhibited while in regions with less severe ischemia, 
oxidative phosphorylation may contribute to a relatively 
greater fraction of ATP synthesis [26]. During normoxia, 
the myofilaments are supplied with a high amount of ATP, 
synthesized from glycolysis and oxidative phosphorylation. 
In normal physiological conditions, high ATP, low ADP and 
inorganic phosphate (Pi) levels maximize the free energy 
available from ATP hydrolysis [26]. During ischemia, the 
activity of aerobic and anaerobic pathways are determined 
both by the amount of residual coronary flow and available 
carbon substrates [26]. Reduced levels of total adenine 
nucleotides (TAN), understood as the sum of ATP, ADP 
and AMP, are characteristics of chronic heart failure. The 
reconditioning of TAN pools leads to an increased energy 
state of the diseased heart [16]. Cave et al. showed that in 
low-flow ischemia simulating a region of acute myocardial 
infarction, oxidative phosphorylation accounted for 90% of 
the ATP synthesis [26]. Analysis of the adenine nucleotide 
correlated with the peak CK-MB and troponin I levels [5], 
a finding not supported in our study. Furthermore, in our 
study, before and four days after PCI, the plasma levels 
of visfatin were negatively correlated with corresponding 
vaspin levels. This may suggest the involvement of vaspin 
in the pathophysiology of coronary artery disease. Vaspin 
has been assumed to be an important risk factor for heart 
disease, associated with cardiovascular disease and 
atherosclerosis-related metabolic variables [10]. Visfatin is 
known to be independently associated with inflammation, 
atherosclerosis and acute coronary syndromes. The 
elevation of visfatin serum levels were observed in patients 
with stable angina, where visfatin plays a role in the pro-
inflammatory process of the atherosclerosis development 
[4]. Based on our findings and available literature, it can 
be assumed that the increased visfatin level could result 
from myocardial cells injury, via ischemic way, and plaque 
Table 2. Correlations between the nucleotides occurring one (I) and 
four (IV) days after PCI.
Day I r(X,Y) r2 p 
ADP vs. AMP 0.703 0.495 0.00001
AMP vs. ATP/ADP -0.827 0.685 0.0000001
AMP vs. NADP -0.452 0.204 0.01
NADP vs. NAD 0.729 0.532 0.000003
NADP vs. ATP/ADP 0.4091 0.1673 0.022
NAD vs. ATP -0.409 0.167 0.022
NAD vs. ATP/ADP 0.392 0.154 0.028
Visfatin vs. Vaspin -0.449 0.201 0.011
Vaspin vs. CRP -0.627 0.394 0.016
Day IV r(X,Y)  r2 p 
NADP vs. UA 0.478 0.228 0.006
NADP vs. ATP 0.864 0.747 0.0000001
NADP vs. ADP 0.762 0.58 0.00001
NADP vs. NAD 0.856 0.733 0.0000001
NADP vs. ATP/ADP 0.822 0.677 0.0000001
NADP vs. VISFATIN 0.7577 0.574 0.000001
NAD vs. UA 0.444 0.197 0.012
NAD vs. ATP 0.791 0.626 0.0000001
NAD vs. ADP 0.622 0.387 0.00018
NAD vs. ATP/ADP 0.722 0.522 0.000004
NAD vs. VISFATIN 0.735 0.541 0.000002
UA vs. ATP/ADP 0.49 0.240 0.005
ATP/ADP vs. VISFATIN 0.752 0.566 0.000001
UA vs. VISFATIN 0.398 0.158 0.02
VISFATIN vs. ADP 0.716 0.512 0.000006
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5  Conclusions
In summary, we focused on patients with acute coronary 
syndrome one day before and four days after PCI. Changes 
in analyzed visfatin and vaspin levels suggest that these 
could be used as potential markers to identify plaque 
destabilization and myocardium necrosis. The monitoring 
of serum visfatin level may be a prognostic factor of 
myocardium regeneration, however, further, detailed 
investigations are required.
Conflict of interest: Authors declare nothing to disclose.
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